Investing in the metaverse will be a key theme over the next decade, one analyst says. Here are seven companies that stand to cash in.
Shares of the COVID-19 vaccine makers Pfizer (NYSE: PFE), Ocugen (NASDAQ: OCGN), and Vaxart (NASDAQ: VXRT) are all moving in the wrong direction today. Specifically, Pfizer's stock is down by approximately 4%, Ocugen's equity is in the red by 5.64%, and Vaxart's shares are underwater by a hefty 8.7%, as of 12:23 p.m. ET Monday afternoon. On Sunday, the White House's chief medical advisor, Dr. Anthony Fauci, said that the preliminary data regarding the severity of the omicron variant was "encouraging."
The global war against COVID-19 has changed over the course of the past week -- and changed dramatically just this past weekend.
High-growth but richly valued tech stocks have been getting hammered by the market as of late, and software cybersecurity disruptor Zscaler (NASDAQ: ZS) hasn't been exempt. As for the specific plunge today (Zscaler is up 36% in 2021 with just weeks to go until the new year), analyst Stephen Bersey at Daiwa Capital downgraded Zscaler to underperform and stuck a $286 price target on the stock. A slew of other Wall Street prognosticators waxed optimistic on Zscaler last week after the company said revenue grew 62% year over year in the last quarter, and deferred revenue (sales collected from customers, but for which service has not yet been provided) boomed 74% higher.
Buffett prefers assets with clear, material use, and these definitely fit the bill.
The stock market stayed in full high-volatility mode on Friday, but investors weren't complaining given the positive tone on Wall Street. Investors seemed comfortable that the Omicron COVID-19 variant isn't likely to flare up into a new full-blown crisis, and that gave investors more confidence in the potential for the global economy to weather any resulting turbulence. Gains for the Dow Jones Industrial Average (DJINDICES: ^DJI), S&P 500 (SNPINDEX: ^GSPC), and Nasdaq Composite (NASDAQINDEX: ^IXIC) were substantial and provided a nice respite from recent declines.
(Bloomberg) -- The Biden administration’s No. 2 energy official was heckled at an international oil conference after admonishing U.S. drillers to step up production in the industry’s de facto hometown.Most Read from BloombergSand and Soldiers Mix as Troops Move In to Protect Cancun TouristsEven in the Metaverse, Not All Identities Are Created EqualThe World's Relentless Demand for Chips Turns Deadly in MalaysiaThe Hot New Trend For Hedge Funds Is—Finally—Female FoundersAutomating the War on Nois
The Wall Street giant really likes these dividend stocks — for very good reasons.
Lucid (LCID) shares opened 12% lower on Monday after the high-end electric vehicle startup revealed it received a subpoena from the Securities and Exchange Commission (SEC) over its recent tie-up with a special purpose acquisition company.
Acadia Pharmaceuticals said late Monday its Rett syndrome treatment succeeded in a pivotal study — and ACAD stock rocketed.
Dr. Stephen Hoge, president of Moderna, said Sunday that there's a risk its vaccine would decrease in effectiveness due to Omicron.
For the past 12 years, investing in growth stocks has been a moneymaking strategy. Historically low lending rates and an accommodative Federal Reserve have allowed fast-paced companies to thrive. Back in 2013, J.P. Morgan Asset Management, a division of JPMorgan Chase, released a report that compared to performance of publicly traded companies that initiated and paid a dividend between 1972 and 2012 to stocks that didn't pay a dividend over the same period.
On Sunday, Dr. Fauci gave a guardedly hopeful update on the omicron variant, and investors in travel and leisure stocks latched onto that hope.
The tech sell-off continued in early trading today, and alternative energy stocks were no exception. Hydrogen fuel technology company Plug Power (NASDAQ: PLUG) initially dropped more than the overall Nasdaq Composite Index, losing more than 6%. It highlighted Elon Musk's view that hydrogen fuel cells aren't the right path for electric vehicle development.
These two under-the-radar metaverse stocks can give attractive returns to retail investors in the long run.
U.S.-listed shares of Alibaba Group Holdings Ltd. rocketed Monday to post their best performance in more than four years as numerous Chinese internet stocks started to mount a comeback after a tough recent stretch.
In a matter of weeks, many growth stocks have gone from hot to cold over fears of an economic slowdown, the omicron COVID-19 variant, and valuation concerns. Lucid Group (NASDAQ: LCID) and Nio (NYSE: NIO) are two very different electric vehicle (EV) companies that are looking to make names for themselves on the global stage. Let's determine if now is the right time to buy Lucid and Nio, or if investors should run for the exits.
Yahoo Finance Live co-hosts Julie Hyman, Brian Cheung, and Brian Sozzi look at Nvidia's shares dipping as EU antitrust regulators pause their investigatory probe into Nvidia's acquisition of chipmaker ARM.
KeyBanc analyst Brandon Nispel placed an overweight rating on Apple. A KeyBanc analyst expects Apple's share price to climb to new highs in the year ahead. Nispel sees three potential catalysts for Apple's business that could drive its share price higher.
Rising inflation is wreaking havoc on many high-growth stocks as investors fret over higher costs and reduced future valuations. Higher interest rates, which counter inflation, are also sparking fears of an economic slowdown and causing investors to rotate from dividend stocks toward lower-risk bonds. Apple (NASDAQ: AAPL) only pays a forward dividend yield of 0.5%, but its low payout ratio of 15% indicates there's still plenty of room for much higher payments.